Laser Photonics Corp 8-K

What Happened

• On April 26, 2026 Laser Photonics Corporation (LASE) entered a warrant inducement agreement with holders of Series A-1 and A-2 warrants. The company received aggregate gross proceeds of $4,000,559.50 and agreed to issue new unregistered Series A-5 and Series A-6 warrants as an inducement to cash exercise of the existing warrants. The existing warrants cover up to 5,715,085 shares (original exercise price $0.70 per share). The new warrants cover a total of 11,430,170 shares — 4,742,860 shares under Series A-5 and 6,687,310 shares under Series A-6 — with an exercise price of $0.975 per share. New warrants become exercisable beginning on the effective date of stockholder approval for the issuance of the underlying shares (the “Initial Exercise Date”).

Key Details

• Gross proceeds received: $4,000,559.50 (closing of warrant inducement agreement).
• New warrants issued: Series A-5 (4,742,860 shares) and Series A-6 (6,687,310 shares); combined 11,430,170 shares; exercise price $0.975/share.
• Existing warrants eligible: up to 5,715,085 shares at original $0.70 exercise price per the S-1.
• Placement agent (H.C. Wainwright & Co., LLC) compensation: 7.0% cash fee on funds raised, a placement-agent warrant for 400,056 shares (7% of shares issued upon exercise of existing warrants) exercisable at $0.875, plus expense reimbursements (up to $75,000) and clearing expenses ($15,950).
• Registration and timing: Company must file an S-1 within 30 days to register the 11,430,170 underlying shares; SEC effectiveness required within either 60 days (if no review) or 90 days (if reviewed). Cash penalties apply if required filing/effectiveness dates are not met.
• Exercise/issuance limits: Beneficial-ownership blocks of 4.99% or 9.99% may be elected by A-1/A-2 holders; withheld shares are held in abeyance but treated as prepaid if exercise price is paid. Restrictions: 30-day moratorium on issuing or announcing new equity or filing related registrations (with exceptions), and a 12-month restriction on variable rate transactions (subject to an exception).

Why It Matters

• The transaction provides immediate cash of about $4.0M and brings potential future capital if new warrants are exercised, but it also creates potential dilution: up to 11.43 million new shares from A-5/A-6 warrants plus placement-agent warrants. Stockholder approval and SEC registration are required before new-warrant exercises for tradable shares, and missed filing deadlines carry cash penalties. The agreement also temporarily limits the company’s ability to issue other equity and enter certain financing transactions, which could affect short-term financing flexibility. Investors should watch for the S-1 filing, the timing of stockholder approval, any SEC review, and the ultimate number of warrants exercised.